Arş. Gör. Dr. Simla ÇOBANOĞLU OLĞAÇ

Eczacılık Fakültesi > Temel Eczacılık Bilimleri > Biyokimya

Bilimsel Toplantı - Kongre ve Görevler

Kongre

  • Olgac A, Budak G, Olgac S, Nuti R, Carotti A, BANOGLU E, 2016. Evias Cloud Based Drug Discovery Platform, High-Performance Modelling and Simulation for Big Data Applications - Management Committee & Working Group Meeting (EU-COST). Dublin, Ireland
  • Olgac A, Budak G, Olgac S, Nuti R, Carotti A, BANOGLU E, 2016. Evias Web Services: Cloud-Based Drug Discovery Platform, 21st European Symposium on Quantitative Structure-Activity Relationship. Verona, Italy
  • Olgac S, Olgac A, Ozkan Y, 2016. Screening FDA Approved Drugs to Discover Potent GPVI Inhibitors, XXIV National Meeting in Medicinal Chemistry. Perugia, Italy
  • Olgac S, Olgac A, Ozkan Y, 2016. Structure-based Virtual Screening to Discover Platelet GPVI Inhibitors, European Platelet Network. Bad Homburg, Germany
  • 2015. Gazi Pharma Symposium Series. Antalya, Turkey
  • 2015. Vienna Summer School on Drug Design. Vienna, Austria
  • Altınay A, Tulmac M, Cobanoglu S, Kısa U, Simsek B, Ozkan Y, 2013. Homocysteine Thiolactonase and LDL Oxidation in Coronary Atherosclerosis, XXV. National Biochemistry Congress. İzmir, Turkey

Makaleler

SCI, SCI-EXP., SSCI, AHCI Tarafından Taranan Makaleler

  • Yurttaş L, Abu Mohsen U, Ozkan Y, Cobanoglu S, Levent S, Kaplancikli ZA. (2016). Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, (1177-83).
  • Yamalı C, Gulcan HO, Kahya B, Cobanoglu S, Sukuroglu MK, Dogruer DS. (2014). Synthesis of some 3(2H)- pyridazinone and 1(2H)-phthalazinone derivatives incorporating aminothiazole moiety and investigation of their antioxidant, acetylcholinesterase, and butyrylcholinesterase inhibitory activities. Medicinal Chemistry Research, (1210–7).